TrialAdvances in therapy2026

Post Hoc Analysis of Recombinant C1 Inhibitor Clinical Data Using Contemporary Endpoints for Hereditary Angioedema.

Marc A Riedl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.